Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.14B
Enterprise Value5.07B
P/E Ratio-211.03
PEG Ratio1.88
Price/Sales Ratio10.53
Price/Book Ratio1.26
Enterprise/Revenue10.24
Enterprise/EBITDA396.73

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.05
Operating Margin-0.06
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue404.72M
Revenue/Share0.84
Gross Profit263.53M
EBITDA60.09M
Net Income14.57M
Diluted EPS0.03

Balance Sheet

Total Cash1.62B
Total Cash/Share3.37
Total Debt19.68M
Total Debt/Equity0.01
Current Ratio20.09
Book Value Per Share7.05

Price History

52-Week Change-44.51
52-Week High16.25
52-Week Low7.77
Moving Average 50 Days9.06
Moving Average 200 Days10.72

Statistics

Average Volume10.84M
Shares Outstanding481.67M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.34
Payout Ratio-0.01
Last Split Factor2:1
Last Split DateJune 29, 2018
AD